Barriers to Implementation of SMART: Views From Pediatric Asthma Specialists
Related Experiment Video
Updated: Jan 9, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
John Paul Jarczyk1, Wayne J Morgan1
1The University of Arizona, Tucson, Arizona, USA.
Insights
Pediatric asthma specialists are familiar with Single Maintenance and Reliever Therapy (SMART) but its adoption varies. Improved EMR efficiency and insurance coverage are key to increasing SMART use.
Area of Science:
- Pediatric Pulmonology
- Asthma Management
- Pharmacotherapy
Background:
- Global Initiative for Asthma (GINA) and National Asthma Education and Prevention Program (NAEPP) guidelines recommend Single Maintenance and Reliever Therapy (SMART) using combination inhaled corticosteroid (ICS)/formoterol inhalers.
- SMART is recommended to replace short-acting beta-agonists (SABA) as preferred reliever therapy for moderate to severe asthma.
- The adoption and influencing factors of SMART among pediatric asthma specialists are not well understood.
Purpose of the Study:
- To investigate the prescribing practices of SMART among pediatric asthma specialists in the United States.
- To identify factors that facilitate or hinder the implementation of SMART in pediatric asthma care.
Main Methods:
- An electronic survey was distributed to pediatric pulmonology division directors for dissemination to pediatric asthma specialists.
- The survey assessed knowledge and practices related to SMART.
Main Results:
- Sixty-eight responses were analyzed from surveys conducted between March and October 2024.
- Over 90% of pediatric asthma specialists were familiar with and comfortable implementing SMART.
- Significant variability in SMART adoption was observed, correlating with region but not clinician comfort or experience.
Conclusions:
- Despite expert recommendations, substantial variation exists in SMART implementation among pediatric asthma specialists.
- Pediatric asthma specialists express comfort with SMART, but barriers such as EMR efficiency and insurance coverage need addressing.
- Enhancing EMR integration and ensuring consistent insurance coverage are crucial for broader SMART adoption.
Background:
The Global Initiative for Asthma (GINA) and National Asthma Education and Prevention Program (NAEPP) both recommend a combination inhaled corticosteroid (ICS)/formoterol inhaler to replace short-acting beta-agonists (SABA) as the preferred reliever therapy for Steps 3 and 4 of their asthma treatment strategies (known as Single Maintenance and Reliever Therapy or SMART). The extent of adoption and factors influencing use among pediatric asthma specialists remain unclear.
Objective:
To gain a better understanding of SMART prescribing practices and factors that facilitate or impede its use in the United States among pediatric asthma specialists.
Methods:
An electronic survey on SMART knowledge and practices was distributed to pediatric pulmonology division directors for dissemination to pediatric asthma specialists in allergy and pulmonology divisions.
Results:
Sixty-eight completed survey responses were received between March and October of 2024. All asthma specialists were familiar with SMART, and over 90% were comfortable with its implementation in pediatric asthma. However, there was wide variability in the percentage of patients advised to use their prescribed maintenance ICS/formoterol inhaler as a reliever that did not correlate with the comfort level of the clinician or years in clinical practice, but did correlate with the region of practice.
Conclusions:
Despite GINA/NAEPP recommending SMART, there is substantial variation in its implementation among pediatric asthma specialists. Survey results indicate that pediatric asthma specialists are comfortable with its use, but that improvement in EMR efficiency and consistent insurance coverage are needed to increase SMART adoption.
More Related Videos
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Inhaled Medications
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-I: Introduction

